Core hcm implementation
Starts Jun 11, 2026Runs until Oct 9, 2026
Office of Personnel Management has already agreed to pay Oracle $1.44M. The job runs until Oct 9, 2026.
Traded Sep 29, 2026 · Filed Oct 1, 2026
A board member of Oracle spent $3.48M of their very own money to buy Oracle shares. Their pile of Oracle shares grew by 6410%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$3,483,800
Shares × reported transaction price
$1M+
+6410.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
19 days after results of Sep 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $137.79 on Sep 29, 2026, 20% above its 52-week low and 56% below its high, after a 6% drop over the previous 30 trading days
52-week range $114.99 (Jul 24, 2026) to $313.00 (Oct 16, 2025), 12% of the way up, from 251 adjusted closes. 30 trading days earlier: $146.65 on Aug 17, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Feb 3, 2026 in the U.S. District Court, D. Delaware. A filing is an allegation, not a finding.
Barrows v. Oracle Corporation, docket 1:26-cv-00127, via CourtListener (court records). Nature of suit 850, company named as first defendant
Core hcm implementation
Starts Jun 11, 2026Runs until Oct 9, 2026
Office of Personnel Management has already agreed to pay Oracle $1.44M. The job runs until Oct 9, 2026.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.